Michael Parini, EVP, CL&AO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 4,598 shares at $238.77 ($1.1M) on 2020-02-06, disclosed to the SEC on 2020-02-07.
Seasonal sale ($1.1M) by EVP, CL&AO — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $238.77 | 1,487 | $355K | 32.3% |
| 2 | $238.77 | 1,487 | $355K | 32.3% |
| 3 | $239.58 | 585 | $140K | 12.7% |
| 4 | $239.58 | 585 | $140K | 12.7% |
| 5 | $240.79 | 300 | $72K | 6.6% |
| 6 | $242.47 | 154 |
| $37K |
| 3.4% |
| Total | $239.23 avg | 4,598 | $1.1M | 100% |
| Filing → |
| VRTX | SELL | 2021-02-16 | $1.7M | — | Filing → |
| VRTX | SELL | 2021-02-09 | $415K | — | Filing → |
| VRTX | SELL | 2021-02-05 | $87K | — | Filing → |